New combo attack on HPV-Linked cancers before surgery
NCT ID NCT05286060
Summary
This study is testing whether a new combination of treatments can better shrink tumors before surgery for head and neck cancers caused by HPV. It is for patients with advanced but operable cancer who have not had prior treatment. The goal is to see if adding a vaccine and other immune-boosting drugs to standard care leads to a stronger response, potentially reducing the amount of cancer left after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yonsei University Health System, Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.